Matches in Nanopublications for { ?s ?p "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP524906.RAy5CqFBBfZkapMO1V4wBbfvZ6P3DYY9D_0xvixS16y6M130_assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524906.RAy5CqFBBfZkapMO1V4wBbfvZ6P3DYY9D_0xvixS16y6M130_provenance.
- NP862690.RAbJveQ0_sI8NCd7MWMZJZFg0Ij6HJ29jOUK8iSPunDog130_assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862690.RAbJveQ0_sI8NCd7MWMZJZFg0Ij6HJ29jOUK8iSPunDog130_provenance.
- NP862691.RAcKzUlvu4Dgb5m6QvUAGpvO9yV9Wj2UsCtfdI818goJ0130_assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862691.RAcKzUlvu4Dgb5m6QvUAGpvO9yV9Wj2UsCtfdI818goJ0130_provenance.
- assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP354304.RAclSs7K87CAHGQ8oPsu_S7Qq9xaVQXXiS4_pqRMeAZYI130_assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354304.RAclSs7K87CAHGQ8oPsu_S7Qq9xaVQXXiS4_pqRMeAZYI130_provenance.
- NP354305.RArtuo1NlGG0fh4pGA6Dfj29408YhCyr_Ws4hx0N2cIqI130_assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354305.RArtuo1NlGG0fh4pGA6Dfj29408YhCyr_Ws4hx0N2cIqI130_provenance.
- NP918039.RANNQSyNRPv1zpjVvBM1X3O7PkKV86awy8HYtdwuDROB0130_assertion description "[Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918039.RANNQSyNRPv1zpjVvBM1X3O7PkKV86awy8HYtdwuDROB0130_provenance.